help button home button Am J Pathol PCR Enhanced. PCRboost from Biomatrica
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Order Full text via Infotrieve
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Limas, C.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Limas, C.

American Journal of Pathology, Vol 139, 131-137, Copyright © 1991 by American Society for Investigative Pathology

REGULAR ARTICLES

Relationship of epidermal growth factor receptor detectability with the A, B, H blood group antigens. Emphasis on normal and neoplastic urothelium [published erratum appears in Am J Pathol 1991 Oct;139(4):following Table of Contents]

C Limas
Department of Laboratory Medicine and Pathology, University of Minnesota, Minneapolis.

The epidermal growth factor receptor (EGFR) is a glycoprotein that carries on its extracellular domains oligosaccharide chains, some of which are similar to blood group determinants. The author examined the expression of the EGFR using immunohistochemistry and three anti-EGFR antibodies with different fine specificities. These were applied to frozen sections from 120 tissue biopsies, including normal and neoplastic urothelium. The expression of blood group A, B, H determinants was also evaluated in the same tissues. Significant differences were noted, depending on the fine specificity of the anti- EGFR antibody, cellular differentiation, and the tissue donor's blood group. The most interesting finding was a reciprocal relationship between the reaction patterns obtained using antibodies with carbohydrate specificity and those with peptide specificity. These patterns were characteristic of cellular differentiation and suggested that the EGFR peptide determinants are detected in excess in immature and malignant cells that, however, appear deficient in oligosaccharide determinants. The combination of 'loss' of blood group antigen and an apparent overexpression of EGFR peptide determinants is indicative of invasive growth in transitional cell carcinomas.




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1991 by the American Society for Investigative Pathology.